There Name
Reviews 1

Medivation provides a decent experience. The website is easy to use, and the customer service is helpful. However, there is room for improvement in terms of product variety. Overall, I am satisfied with my interactions with Medivation.

Tony Frey
Reviews 1

Medivation provides a satisfactory experience. The website is easy to use, and the customer service is friendly and helpful. However, there is room for improvement in terms of product selection. Overall, I am pleased with my interactions with Medivation.

Sanae Azdouffal
Reviews 1

I recently purchased some medical supplies from an online store. I was impressed with the website's ease of use and the wide range of products available. The customer service was also top-notch. I would definitely recommend this company to others.

Blake Wood
Reviews 1

I recently visited a website that sells medical products. The overall experience was good, and I found the website to be easy to navigate. The product selection is impressive, and the prices are competitive. I would definitely recommend it to others.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="medivation" data-lang="en"></div>
More widgets

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of small molecule drugs to treat serious diseases for which there are limited treatment options. Together with its collaboration partner Astellas Pharma Inc. (Astellas), the Company is developing MDV3100 for multiple stages of advanced prostate cancer. As of December 31, 2011, it completed a Phase III trial in the latest stage. The Company's three subsidiaries include Medivation Prostate Therapeutics, Inc. (MPT), Medivation Neurology, Inc. (MNI) and Medivation Technologies, Inc. (MTI). MPT holds the Company’s MDV300 series technology, which is in development for the treatment of advanced prostate cancer, and MTI holds its earlier stage technologies. MNI holds its dimebon technology, which was in development for the treatment of Alzheimer’s disease and Huntington disease.

Categories
Pharmaceuticals